Australia Nobel Winner Develops Edible Vaccine Against Stomach Ulcers
This article was originally published in PharmAsia News
Australia's Nobel-prize winning scientist is said to be working on a method to make an oral vaccine for treating stomach ulcers. Barry Marshall reported a discovery that certain bacteria could be used to make a vaccine that would cling to the stomach wall to prevent ulcers. Marshall, who won the prize for discovering bacteria responsible for the ulcers, founded Ondek, a company that has been searching for a vaccine. He has tried his vaccine successfully in mice and plans to begin human trials later this year. (Click here for more
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.
Dr Reddy’s Laboratories has become the third Revlimid ANDA sponsor to settle patent litigation action with Bristol Myers Squibb’s Celgene. However, the Indian company will join Alvogen in not being able to launch before first settler Natco, which has partnered with Teva’s Watson.